Education
About Us
Working with TipRanks
Follow Us
PROCEPT BioRobotics (PRCT)
NASDAQ:PRCT
PRCT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$47.04 - $103.81
Previous CloseN/A
Volume113.34K
Average Volume (3M)967.70K
Market Cap
$2.76B
Enterprise Value$2.96B
Total Cash (Recent Filing)$316.21M
Total Debt (Recent Filing)$79.81M
Price to Earnings (P/E)―
Beta1.41
Next Earnings
Aug 06, 2025EPS Estimate
-0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.45
Shares Outstanding55,328,667
10 Day Avg. Volume1,531,481
30 Day Avg. Volume967,698
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.07
Enterprise Value/Revenue11.89
Enterprise Value/Gross Profit19.12
Enterprise Value/Ebitda-36.74
Forecast
1Y Price Target
$76.40Price Target Upside52.92% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Bulls Say, Bears Say
Bulls Say
Financial PerformanceProcept Biorobotics Corp pre-announced second quarter revenue 4% above consensus, demonstrating strong commercial momentum.
Growth PotentialLarry Wood has extensive experience in transforming product categories, which is expected to benefit Procept Biorobotics Corp's growth in the BPH surgical market.
LeadershipLarry Wood, an industry veteran, is appointed as the new CEO of Procept Biorobotics Corp, bringing valuable perspective and expertise.
Bears Say
Reimbursement CutsPhysician fees for Aquablation and other resective BPH procedures are projected to decline, with Aquablation fees decreasing by 28%.
Reimbursement RatesThe proposed Medicare physician payment for Aquablation is below previous estimates, which could impact its adoption and utilization.
Stock PerformanceProcept Biorobotics Corp shares are down 27% year-to-date, despite the company's strong financial performance.
PROCEPT BioRobotics News
PRCT FAQ
What was PROCEPT BioRobotics’s price range in the past 12 months?
PROCEPT BioRobotics lowest stock price was $47.04 and its highest was $103.81 in the past 12 months.
What is PROCEPT BioRobotics’s market cap?
PROCEPT BioRobotics’s market cap is $2.76B.
When is PROCEPT BioRobotics’s upcoming earnings report date?
PROCEPT BioRobotics’s upcoming earnings report date is Aug 06, 2025 which is in 2 days.
How were PROCEPT BioRobotics’s earnings last quarter?
PROCEPT BioRobotics released its earnings results on Apr 24, 2025. The company reported -$0.45 earnings per share for the quarter, beating the consensus estimate of -$0.49 by $0.04.
Is PROCEPT BioRobotics overvalued?
According to Wall Street analysts PROCEPT BioRobotics’s price is currently Undervalued.
Does PROCEPT BioRobotics pay dividends?
PROCEPT BioRobotics does not currently pay dividends.
What is PROCEPT BioRobotics’s EPS estimate?
PROCEPT BioRobotics’s EPS estimate is -0.42.
How many shares outstanding does PROCEPT BioRobotics have?
PROCEPT BioRobotics has 55,328,667 shares outstanding.
What happened to PROCEPT BioRobotics’s price movement after its last earnings report?
PROCEPT BioRobotics reported an EPS of -$0.45 in its last earnings report, beating expectations of -$0.49. Following the earnings report the stock price went down -5.637%.
Which hedge fund is a major shareholder of PROCEPT BioRobotics?
Currently, no hedge funds are holding shares in PRCT
PROCEPT BioRobotics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$76.40 (52.92% Upside)
$76.40 (52.92% Upside)
Blogger Sentiment
Bullish
PRCT Sentiment 75%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 464.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 2.6%
Last 30 Days ▼ 2.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.41%
12-Months-Change
Fundamentals
Return on Equity
-27.62%
Trailing 12-Months
Asset Growth
35.64%
Trailing 12-Months
Company Description
PROCEPT BioRobotics
PROCEPT BioRobotics Corporation (PRCT) is a medical technology company specializing in the development of innovative robotic solutions for the treatment of urological diseases. The company's flagship product, the AquaBeam Robotic System, utilizes advanced imaging and robotics to perform minimally invasive surgery for benign prostatic hyperplasia (BPH), a common condition affecting older men. By focusing on enhancing patient outcomes and reducing the side effects associated with traditional surgical methods, PROCEPT BioRobotics aims to revolutionize the standard of care in the urology sector.
PRCT Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call demonstrated strong revenue growth and strategic advancements, particularly in system sales and Medicare coverage, but was tempered by significant net losses and potential tariff impacts.Read More>PRCT Stock 12 Month Forecast
Average Price Target
$76.40
▲(52.92%Upside)
Technical Analysis
Ownership Overview
2.65% Insiders
36.53% Mutual Funds
0.13% Other Institutional Investors
44.66% Public Companies and
Individual Investors